|4Jan 18, 4:32 PM ET

Gold Lawrence Marshall 4

4 · 180 Life Sciences Corp. · Filed Jan 18, 2022

Insider Transaction Report

Form 4
Period: 2022-01-14
Transactions
  • Award

    Common Stock

    2022-01-14$3.04/sh+4,728$14,37311,458 total
Footnotes (1)
  • [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit Committee and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

Documents

1 file
  • 4
    ownership.xmlPrimary